Insider Selling: Lifevantage (NASDAQ:LFVN) Director Sells $48,900.00 in Stock

Lifevantage Corporation (NASDAQ:LFVN – Get Free Report) Director Michael Beindorff sold 10,000 shares of the company’s stock in a transaction that occurred on Thursday, November 12th. The stock was sold at an average price of $4.89, for a total value of $48,900.00. Following the completion of the sale, the director owned 31,625 shares in the company, valued at approximately $154,646.25. This represents a 24.02% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Lifevantage Stock Down 4.0%

Shares of NASDAQ LFVN traded down $0.20 during midday trading on Monday, reaching $4.77. 118,381 shares of the stock were exchanged, compared to its average volume of 213,491. The firm has a market cap of $60.49 million, a price-to-earnings ratio of 22.72 and a beta of 0.71. Lifevantage Corporation has a twelve month low of $3.90 and a twelve month high of $11.71. The firm has a 50-day simple moving average of $5.93 and a two-hundred day simple moving average of $5.86.

Lifevantage (NASDAQ:LFVN – Get Free Report) last posted its earnings results on Monday, November 9th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.06 by ($0.01). Lifevantage had a net margin of 1.58% and a return on equity of 16.35%. The firm had revenue of $37.12 million for the quarter, compared to analysts’ expectations of $40.49 million.

Lifevantage Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Tuesday, December 1st will be given a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a yield of 4.2%. The ex-dividend date is Tuesday, December 1st. Lifevantage’s dividend payout ratio (DPR) is currently 95.24%.

Institutional Investors Weigh In On Lifevantage

A number of institutional investors have recently added to or reduced their stakes in LFVN. Engineers Gate Manager LP increased its holdings in Lifevantage by 109.7% in the 2nd quarter. Engineers Gate Manager LP now owns 27,009 shares of the company’s stock worth $169,000 after acquiring an additional 14,131 shares in the last quarter. Bank of New York Mellon Corp lifted its holdings in Lifevantage by 11.9% during the first quarter. Bank of New York Mellon Corp now owns 33,547 shares of the company’s stock valued at $145,000 after purchasing an additional 3,571 shares in the last quarter. Bank of America Corp DE lifted its holdings in Lifevantage by 24.3% during the first quarter. Bank of America Corp DE now owns 23,445 shares of the company’s stock valued at $101,000 after purchasing an additional 4,586 shares in the last quarter. Finally, Hsbc Holdings PLC acquired a new stake in shares of Lifevantage in the first quarter valued at about $51,000. Institutional investors and hedge funds own 35.32% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on LFVN. Weiss Ratings cut shares of Lifevantage from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday. Lake Street Capital increased their target price on shares of Lifevantage from $5.00 to $6.00 and gave the stock a “hold” rating in a research note on Friday, August 28th. UBS Group set a $8.00 target price on shares of Lifevantage in a research note on Friday. Zacks Research cut Lifevantage from a “hold” rating to a “strong sell” rating in a research report on Friday, October 16th. Finally, Freedom Broker cut their price target on Lifevantage from $9.00 to $8.00 and set a “buy” rating for the company in a research note on Friday. One equities research analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Lifevantage has a consensus rating of “Hold” and a consensus price target of $6.75.

View Our Latest Stock Report on Lifevantage

Lifevantage Company Profile

(Get Free Report)

LifeVantage Corporation is a health and wellness company that develops and sells dietary supplements, skincare products and other wellness offerings. Its product range includes Protandim supplements and the TrueScience skincare line, with products marketed around the company’s focus on nutrigenomics—the study of how nutrition interacts with gene expression. Founded in 2003, LifeVantage primarily sells through independent consultants and online channels. The company serves customers in markets across North America, Europe and the Asia-Pacific region.

See Also

Insider Buying and Selling by Quarter for Lifevantage (NASDAQ:LFVN)

Receive News & Ratings for Lifevantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lifevantage and related companies with MarketBeat.com's FREE daily email newsletter.